In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers?

dc.creator	Valotassiou V., Angelidis G., Psimadas D., Tsougos I., Georgoulias P.	en
dc.date.accessioned	2023-01-31T10:25:06Z
dc.date.available	2023-01-31T10:25:06Z
dc.date.issued	2020
dc.identifier	10.1007/s00259-020-05077-2
dc.identifier.issn	16197070
dc.identifier.uri	http://hdl.handle.net/11615/80361
dc.description.abstract	[No abstract available]	en
dc.language.iso	en	en
dc.source	European Journal of Nuclear Medicine and Molecular Imaging	en
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85092787202&doi=10.1007%2fs00259-020-05077-2&partnerID=40&md5=89849f4680504c507f17844c89c7d23f
dc.subject	biological marker	en
dc.subject	fluorodeoxyglucose f 18	en
dc.subject	Alzheimer disease	en
dc.subject	brain	en
dc.subject	diagnostic imaging	en
dc.subject	human	en
dc.subject	perfusion	en
dc.subject	positron emission tomography	en
dc.subject	single photon emission computed tomography	en
dc.subject	Alzheimer Disease	en
dc.subject	Biomarkers	en
dc.subject	Brain	en
dc.subject	Fluorodeoxyglucose F18	en
dc.subject	Humans	en
dc.subject	Perfusion	en
dc.subject	Positron-Emission Tomography	en
dc.subject	Tomography, Emission-Computed, Single-Photon	en
dc.subject	Springer Science and Business Media Deutschland GmbH	en
dc.title	In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers?	en
dc.type	other	en

Files in questo item

Files	Dimensione	Formato	Mostra
Nessun files in questo item.